US biopharmaceutical company iVeena has submitted an Investigational New Drug (IND) application to the US Food and Drug Administration (FDA) for its IVMED-85 eye drop for the treatment of paediatric m
Converting infrared light into visible light, scientists have created contact lenses (CLs) enabling infrared vision in both humans and mice. Unlike infrared night-vision goggles, the CLs, desc
Three-month interim results from a study led by the National Vision Research Institute, Australian College of Optometry, found repeated low-level red-light (RLRL) therapy effective and safe in control
Two EI optometrists are progressing through the accreditation programme for performing YAG laser capsulotomies.
Researchers in Australia found successful dry eye disease (DED) treatment with ocular lubricants also diminished migraine severity in susceptible patients.
The first Eye Institute optometry seminar for 2025 eschewed the usual format of guest lecturers and quickfire presentations of unusual cases in favour of a more relaxed and entertaining wrestling matc
Dual honours for Prof Helen Danesh-Meyer
Building on three years of delivering tailored insurance solutions for optometry, Clarity Insurance Brokers is now expanding OptiSure to include ophthalmology.
US researchers found no significant long-term differences in retinal vascular metrics between patients receiving intravitreal injections (IVI) of anti-VEGF and non-injection control groups.
Highlighting the importance of earlier diagnosis and intervention, a team from the University of Bristol have developed new treatment guidance to help tackle uveitis. “Uveitis is often detect
A strabismus and amblyopia treatment which uses a virtual reality (VR) headset to treat binocular vision has been approved for use in eight- to 12-year-old patients by the US Food and Drug Administrat
An international clinical trial, that included Auckland University researcher Dr Rachael Niederer, has found that one year of suppressive treatment with valacyclovir was associated with a lower dosage
